JUMLAH TROMBOSIT PASIEN DHF DENGAN TERAPI KONSENTRAT TROMBOSIT

  • Dewi Astuti Poltekkes Kemenkes Jakarta III
  • Atika setianingrum
  • Delly Navita
  • Eva Ayu Maharani
Keywords: Platelet concentrate, Pre transfusion, Post transfusion

Abstract

Bacground: Dengue fever is a disease caused by the dengue fever virus. Clinical manifestations of dengue fever can cause bleeding associated with thrombocytopenia. Platelet transfusions are used to manage dengue fever. Previous research found that platelets count after Apheresis Platelet transfusion was higher than using Platelet Concentrate. This research will be carried out to determine the number of platelets in dengue fever patients with platelet concentrate therapy. Methdes : The research design used was a descriptive observational study using 40 data on platelet count examinations before and after platelet concentrate transfusion at the hospital. Dr. Iqbali Taufan in 2021-2022. Results: The frequency of DHF patients with platelet concentrate therapy was 70% male and 30% female. DHF patients with platelet concentrate therapy are predominantly adults (26-45 years) was 70%. The results of the platelet count before the transfusion of Thrombocy Concentrate from a total of 40 patients were minimum 8,000/µL, maximum 87,000/µL, and an average count was 23,875/µL. The platelet count after transfusion of Platelet Concentrate were minimum 16,000/µL, maximum of 185,000/µL, and an average count was 92,350/µL. Conclusion: The frequency of DHF patients with platelet concentrate therapy is 70% male and 70% adult (26-45 years). The average number of platelets before the Platelet Concentrate was transfused was 23,875/µL and after the transfusion was 92,350/µL. 

 

Keyword: Platelet concentrate, Pre transfusion, Post transfusion

 

References

Azimata Rosyidah, R., Anjani, N., Murni Hartini, W., Mardiyaningsih Program Studi, A. D., Bank Darah, T., Kesehatan Bhakti Setya Indonesia BDRS, P., Persahabatan, R., Kesehatan Bhakti Setya Indonesia Program Studi, P. D., & Kesehatan Bhakti, P. (2023). Perbedaan Jumlah Trombosit Pasca Transfusi Thrombocyte Concentrate Dan Thrombocyte Apheresis Pada Pasien Trombositopenia. Health Journal “Love That Renews,” 11, 169–182.
Dewi, S. A. P. S. A. (2016). Peningkatan Jumlah Trombosit Setelah Pemberian Transfusi Tromosit Apheresis pada Anak dengan Penyakit Keganasan Disertai Trombositopenia Refrakter.
Khetarpal, N., & Khanna, I. (2016). Dengue Fever: Causes, Complications, and Vaccine Strategies. In Journal of Immunology Research (Vol. 2016). Hindawi Publishing Corporation. https://doi.org/10.1155/2016/6803098
Mulyo Sostro. (2015). Transfusi Trombosit Profi laksis pada Demam Berdarah Dengue: Bermanfaat atau Merugikan?
Sumantri, T., Studi Pendidikan Dokter, P., Kedokteran dan Ilmu Kesehatan, F., Muhammadiyah Yogyakarta, U., & Patologi Klinik, B. (2011). Perbedaan Angka Trombosit pada Pasien DHF Setelah Pemberian Transfusi PRP (Platelet Rich Plasma) dengan TC (Thrombocyte Concentrate) Difference Number of Thrombocytes in DHF Patients After Giving the PRP (Platelet Rich Plasma) Transfusion with TC (Thrombocyte Concentrate). Mutiara Medika, 11(3), 181–188.
Syafitri, R., & Shoumi, D. (2021). Perbedaan Kadar Trombosit pada Pasien Trombositopenia Sebelum dan Sesudah Transfusi Trombosit Konsentrat di RSUD KArawang Tahun 2019-2020. Ensiklopedia of Journal, 3(3), 107–113.
Tirtadevi, S. N., Riyanti, R., & Wisudanti, D. D. (2021). Correlation of Platelet Count and Hematocrit Levels to the Severity of Dengue Hemorrhagic Fever Patients at RSD dr. Soebandi Jember. Journal of Agromedicine and Medical Sciences. 2021, 7(3), 156–161. https://doi.org/10.19184/ams.v7i3.2436
Wibowo, K., Juffrie Mohammad, Laksanawati, I. S., & Mulatsih, S. (2011). Pengaruh Transfusi Trombosit terhadap Terjadinya Perdarahan Masif pada Demam Berdarah Dengue. Sari Pediatri, 12, 404–408.
Published
2023-10-31
How to Cite
Astuti, D., setianingrum, A., Navita, D., & Maharani, E. (2023). JUMLAH TROMBOSIT PASIEN DHF DENGAN TERAPI KONSENTRAT TROMBOSIT. Jurnal Fisioterapi Dan Kesehatan Indonesia, 3(2), 121-126. https://doi.org/10.59946/jfki.2023.237